Trial of Tocilizumab for Treatment of Severe COVID-19: ARCHITECTS
Clinical trial NCT04412772 · TERMINATED
Trial details
- NCT number
- NCT04412772
- Sponsor
- Queen's Medical Center
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-12
- Primary completion
- 2021-03-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.